Antimicrobial and Antibiofilm Activity of Monolaurin against Methicillin-Resistant Staphylococcus aureus Isolated from Wound Infections
Methicillin-resistant (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA. The agar dilution method determined the minimum inhibitory concentration...
Saved in:
Published in | International journal of microbiology Vol. 2024; no. 1; p. 7518368 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Egypt
John Wiley & Sons, Inc
2024
Hindawi Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Methicillin-resistant
(MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA.
The agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin's antibiofilm activity and its inhibitory concentration (IC
), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT-PCR) discerned a monolaurin effect on the expression of the
gene.
Monolaurin exhibited MIC values ranging from 500 to 2000
g/mL. FIC index showed a synergistic effect of monolaurin with
-lactam antibiotics ranging from 0.0039 to 0.25 (
< 0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin's capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC
values of 203.6
g/mL and 379.3
g/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the
gene were remarkably reduced at monolaurin concentrations of 250 and 500
g/mL.
Monolaurin had significant inhibitory effects on MRSA pre-existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter-associated infections. |
---|---|
AbstractList | Background. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA. Methods. The agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin’s antibiofilm activity and its inhibitory concentration (IC50), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT-PCR) discerned a monolaurin effect on the expression of the icaD gene. Results. Monolaurin exhibited MIC values ranging from 500 to 2000 μg/mL. FIC index showed a synergistic effect of monolaurin with β-lactam antibiotics ranging from 0.0039 to 0.25 (p<0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin’s capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC50 values of 203.6 μg/mL and 379.3 μg/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the icaD gene were remarkably reduced at monolaurin concentrations of 250 and 500 μg/mL. Conclusion. Monolaurin had significant inhibitory effects on MRSA pre-existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter-associated infections. Methicillin-resistant (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA. The agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin's antibiofilm activity and its inhibitory concentration (IC ), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT-PCR) discerned a monolaurin effect on the expression of the gene. Monolaurin exhibited MIC values ranging from 500 to 2000 g/mL. FIC index showed a synergistic effect of monolaurin with -lactam antibiotics ranging from 0.0039 to 0.25 ( < 0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin's capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC values of 203.6 g/mL and 379.3 g/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the gene were remarkably reduced at monolaurin concentrations of 250 and 500 g/mL. Monolaurin had significant inhibitory effects on MRSA pre-existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter-associated infections. Background . Methicillin‐resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life‐threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm‐forming MRSA. Methods . The agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin’s antibiofilm activity and its inhibitory concentration (IC 50 ), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT‐PCR) discerned a monolaurin effect on the expression of the icaD gene. Results . Monolaurin exhibited MIC values ranging from 500 to 2000 μ g/mL. FIC index showed a synergistic effect of monolaurin with β ‐lactam antibiotics ranging from 0.0039 to 0.25 ( p < 0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin’s capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC 50 values of 203.6 μ g/mL and 379.3 μ g/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the icaD gene were remarkably reduced at monolaurin concentrations of 250 and 500 μ g/mL. Conclusion . Monolaurin had significant inhibitory effects on MRSA pre‐existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter‐associated infections. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA.BackgroundMethicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA.The agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin's antibiofilm activity and its inhibitory concentration (IC50), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT-PCR) discerned a monolaurin effect on the expression of the icaD gene.MethodsThe agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin's antibiofilm activity and its inhibitory concentration (IC50), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT-PCR) discerned a monolaurin effect on the expression of the icaD gene.Monolaurin exhibited MIC values ranging from 500 to 2000 μg/mL. FIC index showed a synergistic effect of monolaurin with β-lactam antibiotics ranging from 0.0039 to 0.25 (p < 0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin's capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC50 values of 203.6 μg/mL and 379.3 μg/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the icaD gene were remarkably reduced at monolaurin concentrations of 250 and 500 μg/mL.ResultsMonolaurin exhibited MIC values ranging from 500 to 2000 μg/mL. FIC index showed a synergistic effect of monolaurin with β-lactam antibiotics ranging from 0.0039 to 0.25 (p < 0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin's capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC50 values of 203.6 μg/mL and 379.3 μg/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the icaD gene were remarkably reduced at monolaurin concentrations of 250 and 500 μg/mL.Monolaurin had significant inhibitory effects on MRSA pre-existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter-associated infections.ConclusionMonolaurin had significant inhibitory effects on MRSA pre-existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter-associated infections. Background. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study aimed to assess the influence of monolaurin on biofilm-forming MRSA. Methods. The agar dilution method determined the minimum inhibitory concentration (MIC) of monolaurin against MRSA isolates and explored its impact on the resistance profile of selected antibiotics. The assessment of combined therapy involving monolaurin and antibiotics was conducted using fractional inhibitory concentration (FIC). The tissue culture plate strategy appraised monolaurin's antibiofilm activity and its inhibitory concentration (IC[sub.50]), with assessment via scanning electron microscopy. Reverse transcription polymerase chain reaction (RT-PCR) discerned a monolaurin effect on the expression of the icaD gene. Results. Monolaurin exhibited MIC values ranging from 500 to 2000μ g/mL. FIC index showed a synergistic effect of monolaurin with β -lactam antibiotics ranging from 0.0039 to 0.25 (p<0.001). Among the 103 investigated MRSA isolates, 44 (44.7%) displayed moderate biofilm formation, while 59 (55.3%) were strong biofilm producers. Antibiofilm activity demonstrated concentration dependence, confirming monolaurin's capacity to inhibit biofilm formation and exhibited strong eradicating effects against preformed MRSA biofilms with IC[sub.50] values of 203.6μ g/mL and 379.3μ g/mL, respectively. Scanning electron microscope analysis revealed reduced cell attachments and diminished biofilm formation compared to the control. The expression levels of the icaD gene were remarkably reduced at monolaurin concentrations of 250 and 500μ g/mL. Conclusion. Monolaurin had significant inhibitory effects on MRSA pre-existing biofilms as well as biofilm development. So, it can be employed in the treatment of severe infections, particularly those associated with biofilm formation including catheter-associated infections. |
Audience | Academic |
Author | Mustafa, Ahmad Osama El-Gendy, Ahmed Abourehab, Mohammed A S El-Beeh, Mohamed E Ibrahem, Reham Ali Azmy, Ahmed Farag Abd El-Baky, Rehab Mahmoud Hassan Abd El-Ghany, Shimaa Salah |
Author_xml | – sequence: 1 givenname: Shimaa Salah orcidid: 0009-0007-3382-956X surname: Hassan Abd El-Ghany fullname: Hassan Abd El-Ghany, Shimaa Salah organization: Department of Microbiology and Immunology Faculty of Pharmacy Deraya University, Minia 11566, Egypt – sequence: 2 givenname: Ahmed Farag orcidid: 0000-0002-7347-9564 surname: Azmy fullname: Azmy, Ahmed Farag organization: Department of Microbiology and Immunology Faculty of Pharmacy Beni-Suef University, Beni-Suef 62514, Egypt – sequence: 3 givenname: Ahmed orcidid: 0000-0002-0980-5185 surname: Osama El-Gendy fullname: Osama El-Gendy, Ahmed organization: Department of Microbiology and Immunology Faculty of Pharmacy Beni-Suef University, Beni-Suef 62514, Egypt – sequence: 4 givenname: Rehab Mahmoud orcidid: 0000-0001-6094-5653 surname: Abd El-Baky fullname: Abd El-Baky, Rehab Mahmoud organization: Department of Microbiology and Immunology Faculty of Pharmacy Minia University, Minia 61519, Egypt – sequence: 5 givenname: Ahmad orcidid: 0000-0001-7254-5665 surname: Mustafa fullname: Mustafa, Ahmad organization: Faculty of Engineering October University for Modern Science and Arts (MSA), Giza, Egypt – sequence: 6 givenname: Mohammed A S surname: Abourehab fullname: Abourehab, Mohammed A S organization: Department of Pharmaceutics Faculty of Pharmacy Umm Al-Qura University, Makkah 21955, Saudi Arabia – sequence: 7 givenname: Mohamed E surname: El-Beeh fullname: El-Beeh, Mohamed E organization: Biology Department Al-Jumum University College Umm Al-Qura University, Makkah 21955, Saudi Arabia – sequence: 8 givenname: Reham Ali orcidid: 0000-0002-3249-4290 surname: Ibrahem fullname: Ibrahem, Reham Ali organization: Department of Microbiology and Immunology Faculty of Pharmacy Minia University, Minia 61519, Egypt |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39129910$$D View this record in MEDLINE/PubMed |
BookMark | eNptksuKFDEUhgsZcS66cy0BNy7smVwqVcmyGUZtmEHwgu7CqVx60lQlY5IS-gl8bdN226JIFiccvv9cOP95cxJisE3znOBLQji_opi2Vz0ngnXiUXNGOtEvJJHi5PgXX0-b85w3GHeCcvmkOWWSUCkJPmt-LEPxk9cpDh5GBMGgXWbw0flxQktd_Hdftig6dBdDHGFOPiBYgw-5oDtb7r324-jD4oPNPhcIBX0s8HC_HaOOWs8ZVYmtYZWruliDXIoT-hLn2moVnK0dYshPm8cOxmyfHeJF8_nNzafrd4vb929X18vbhWZ9XxbE9YYCde1AiOm46I3ujGGaMwOODD21zrV44MbVv3SOgmuht5RCr6EnhF00q31dE2GjHpKfIG1VBK9-JWJaK0jF69Gqoe0YdFZjEKbV3EBrOiYp5oMWVjtea73a13pI8dtsc1GTz9qOIwQb56wYrjSWTOCKvvwH3cQ5hbrpjiKMCynaP9Qaan8fXCwJ9K6oWgrc8jo_lZW6_A9Vn7H1kNUc9XL2b8HrvaBeOedk3XFvgtXOQ2rnIXXwUMVfHGadh8maI_zbNOwnAqrEqA |
Cites_doi | 10.1016/s0255-0857(21)02466-x 10.13005/ojc/340233 10.12669/pjms.38.8.6276 10.3389/fmicb.2018.02749 10.1038/sj.clpt.6100247 10.1111/j.1574-695x.2007.00357.x 10.5812/archcid.65744 10.1186/1756-0500-3-260 10.3390/pathogens2020288 10.1002/9781119246329.ch22 10.4103/jdmimsu.jdmimsu_156_21 10.1186/s12879-024-09261-9 10.1155/2013/378492 10.1186/1471-2105-7-85 10.1155/2019/8321834 10.1016/j.tim.2004.11.010 10.1007/s10096-017-3014-8 10.1007/s00203-017-1396-8 10.1002/cben.202100050 10.54393/pjhs.v3i04.139 10.1016/j.jhin.2012.07.010 10.2217/fmb.15.68 10.1111/j.1745-4530.2007.00178.x 10.1002/cmdc.202000677 10.1016/j.lwt.2020.109208 10.1208/s12249-014-0141-8 10.1186/1751-0147-54-69 10.3390/ijerph192114134 10.15376/biores.18.1.1554-1576 10.1128/JCM.00966-20 10.1371/journal.pone.0007499 10.1128/aac.00442-17 10.1371/journal.pone.0040350 10.1186/s40064-016-3182-5 10.1128/jcm.01864-19 10.1089/mdr.2018.0033 10.3390/diseases9040080 10.1089/mdr.2020.0001 10.1128/aac.47.4.1391-1394.2003 10.1038/nrmicro2415 10.3389/fmicb.2020.566325 10.1016/j.vetmic.2008.09.011 10.1186/s40360-017-0141-x 10.1038/s41522-022-00306-y 10.5144/0256-4947.2012.513 10.22207/jpam.17.1.44 10.1186/s12906-021-03293-3 10.1186/s13104-018-3820-9 10.1038/nrmicro.2016.94 10.3390/antibiotics9020059 10.1002/jobm.201700071 10.1111/j.1469-0691.2011.03570.x 10.1155/2016/5751785 10.1016/j.lwt.2016.03.045 10.1007/s13204-014-0301-x 10.3390/antibiotics11081083 10.1007/s43994-022-00018-1 10.1128/aac.02008-12 10.1385/1-59745-468-0:127 10.1038/nrd1008 |
ContentType | Journal Article |
Copyright | Copyright © 2024 Shimaa Salah Hassan Abd El-Ghany et al. COPYRIGHT 2024 John Wiley & Sons, Inc. Copyright © 2024 Shimaa Salah Hassan Abd El-Ghany et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 |
Copyright_xml | – notice: Copyright © 2024 Shimaa Salah Hassan Abd El-Ghany et al. – notice: COPYRIGHT 2024 John Wiley & Sons, Inc. – notice: Copyright © 2024 Shimaa Salah Hassan Abd El-Ghany et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 |
DBID | NPM AAYXX CITATION 3V. 7QL 7T7 7U9 7X7 7XB 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU CWDGH DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M7N M7P P64 PIMPY PQEST PQQKQ PQUKI PRINS 7X8 DOA |
DOI | 10.1155/2024/7518368 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College Middle East & Africa Database ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central Health Research Premium Collection Middle East & Africa Database Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Collection AIDS and Cancer Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1687-9198 |
Editor | Dilarri, Guilherme |
Editor_xml | – sequence: 1 givenname: Guilherme surname: Dilarri fullname: Dilarri, Guilherme – fullname: Guilherme Dilarri |
ExternalDocumentID | oai_doaj_org_article_b463a6ec0a8d4c5da4d639205bc8ecf5 A804511329 10_1155_2024_7518368 39129910 |
Genre | Journal Article |
GeographicLocations | Egypt |
GeographicLocations_xml | – name: Egypt |
GroupedDBID | 188 24P 29J 2UF 2WC 3V. 4.4 53G 5GY 5VS 7X7 8FE 8FH 8FI 8FJ 8R4 8R5 AAFWJ AAJEY ABDBF ABUWG ACPRK ADBBV ADRAZ AFKRA AFPKN AFRAH AHMBA AINHJ ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C1A CCPQU CEFSP CNMHZ CWDGH DIK E3Z EBS EJD ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IEA IHR IL9 IPNFZ ITC KQ8 LK8 M48 M7P MM. M~E NPM O5R O5S OK1 PGMZT PIMPY PQQKQ PROAC Q2X RHU RHX RIG RNS RPM TR2 TUS UKHRP UZ5 ~8M AAYXX CITATION 7QL 7T7 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. M7N P64 PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c377t-1f7d2a2f4b11d6587dc6dd3c53daf1b72eff40b5dfb729ff2af4a7e22a7ca7113 |
IEDL.DBID | M48 |
ISSN | 1687-918X |
IngestDate | Tue Oct 22 15:15:01 EDT 2024 Sat Oct 26 04:26:33 EDT 2024 Thu Oct 10 22:19:46 EDT 2024 Wed Oct 16 18:02:07 EDT 2024 Tue Oct 15 04:49:24 EDT 2024 Thu Aug 22 14:18:08 EDT 2024 Sat Nov 02 12:16:13 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Copyright © 2024 Shimaa Salah Hassan Abd El-Ghany et al. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c377t-1f7d2a2f4b11d6587dc6dd3c53daf1b72eff40b5dfb729ff2af4a7e22a7ca7113 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-3249-4290 0000-0001-7254-5665 0000-0002-7347-9564 0000-0001-6094-5653 0000-0002-0980-5185 0009-0007-3382-956X |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2024/7518368 |
PMID | 39129910 |
PQID | 3091358984 |
PQPubID | 237261 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b463a6ec0a8d4c5da4d639205bc8ecf5 proquest_miscellaneous_3092009380 proquest_journals_3091358984 gale_infotracmisc_A804511329 gale_infotracacademiconefile_A804511329 crossref_primary_10_1155_2024_7518368 pubmed_primary_39129910 |
PublicationCentury | 2000 |
PublicationDate | 2024-00-00 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – year: 2024 text: 2024-00-00 |
PublicationDecade | 2020 |
PublicationPlace | Egypt |
PublicationPlace_xml | – name: Egypt – name: New York |
PublicationTitle | International journal of microbiology |
PublicationTitleAlternate | Int J Microbiol |
PublicationYear | 2024 |
Publisher | John Wiley & Sons, Inc Hindawi Limited |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Hindawi Limited |
References | e_1_2_13_24_2 e_1_2_13_26_2 e_1_2_13_45_2 e_1_2_13_20_2 e_1_2_13_43_2 e_1_2_13_22_2 e_1_2_13_64_2 e_1_2_13_8_2 e_1_2_13_62_2 e_1_2_13_6_2 e_1_2_13_60_2 Krislee A. (e_1_2_13_47_2) 2019 e_1_2_13_17_2 e_1_2_13_38_2 Jafari-Sales A. (e_1_2_13_41_2) 2018; 1 e_1_2_13_13_2 e_1_2_13_34_2 e_1_2_13_15_2 e_1_2_13_36_2 e_1_2_13_57_2 Tajik H. (e_1_2_13_50_2) 2014; 1 e_1_2_13_30_2 e_1_2_13_55_2 e_1_2_13_11_2 e_1_2_13_32_2 e_1_2_13_51_2 Wang H. (e_1_2_13_53_2) 2020; 124 Mochtar C. F. (e_1_2_13_59_2) 2021; 13 e_1_2_13_4_2 e_1_2_13_2_2 e_1_2_13_27_2 e_1_2_13_29_2 e_1_2_13_23_2 e_1_2_13_48_2 e_1_2_13_25_2 e_1_2_13_46_2 e_1_2_13_44_2 e_1_2_13_65_2 e_1_2_13_21_2 e_1_2_13_42_2 e_1_2_13_63_2 e_1_2_13_61_2 e_1_2_13_7_2 e_1_2_13_40_2 e_1_2_13_5_2 e_1_2_13_9_2 Mader R. (e_1_2_13_31_2) 2021; 26 e_1_2_13_16_2 e_1_2_13_39_2 e_1_2_13_18_2 e_1_2_13_12_2 e_1_2_13_37_2 e_1_2_13_56_2 e_1_2_13_54_2 e_1_2_13_10_2 e_1_2_13_33_2 e_1_2_13_52_2 Schlievert P. M. (e_1_2_13_58_2) 2012; 7 Mishra R. (e_1_2_13_35_2) 2020; 11 Khan A. A. (e_1_2_13_14_2) 2017 e_1_2_13_3_2 e_1_2_13_1_2 e_1_2_13_28_2 e_1_2_13_49_2 Albano M. (e_1_2_13_19_2) 2020; 59 |
References_xml | – start-page: 1 volume-title: BMC Proceedings year: 2019 ident: e_1_2_13_47_2 contributor: fullname: Krislee A. – ident: e_1_2_13_22_2 doi: 10.1016/s0255-0857(21)02466-x – ident: e_1_2_13_48_2 doi: 10.13005/ojc/340233 – ident: e_1_2_13_56_2 doi: 10.12669/pjms.38.8.6276 – ident: e_1_2_13_23_2 doi: 10.3389/fmicb.2018.02749 – ident: e_1_2_13_6_2 doi: 10.1038/sj.clpt.6100247 – ident: e_1_2_13_3_2 doi: 10.1111/j.1574-695x.2007.00357.x – ident: e_1_2_13_1_2 doi: 10.5812/archcid.65744 – ident: e_1_2_13_63_2 doi: 10.1186/1756-0500-3-260 – ident: e_1_2_13_32_2 doi: 10.3390/pathogens2020288 – start-page: 439 volume-title: Biofilms in Plant and Soil Health year: 2017 ident: e_1_2_13_14_2 doi: 10.1002/9781119246329.ch22 contributor: fullname: Khan A. A. – ident: e_1_2_13_42_2 doi: 10.4103/jdmimsu.jdmimsu_156_21 – ident: e_1_2_13_52_2 doi: 10.1186/s12879-024-09261-9 – ident: e_1_2_13_64_2 doi: 10.1155/2013/378492 – ident: e_1_2_13_29_2 doi: 10.1186/1471-2105-7-85 – ident: e_1_2_13_38_2 doi: 10.1155/2019/8321834 – ident: e_1_2_13_11_2 doi: 10.1016/j.tim.2004.11.010 – ident: e_1_2_13_43_2 doi: 10.1007/s10096-017-3014-8 – volume: 1 start-page: 108 year: 2014 ident: e_1_2_13_50_2 article-title: Effect of monolaurin alone and in combination with EDTA on viability of Escherichia coli and Staphylococcus aureus in culture media and iranian white cheese publication-title: Journal of Food Quality and Hazards Control contributor: fullname: Tajik H. – ident: e_1_2_13_27_2 doi: 10.1007/s00203-017-1396-8 – ident: e_1_2_13_65_2 doi: 10.1002/cben.202100050 – ident: e_1_2_13_36_2 doi: 10.54393/pjhs.v3i04.139 – ident: e_1_2_13_62_2 doi: 10.1016/j.jhin.2012.07.010 – ident: e_1_2_13_51_2 doi: 10.2217/fmb.15.68 – ident: e_1_2_13_18_2 doi: 10.1111/j.1745-4530.2007.00178.x – ident: e_1_2_13_30_2 doi: 10.1002/cmdc.202000677 – volume: 124 year: 2020 ident: e_1_2_13_53_2 article-title: Antibacterial effects of Lactobacillus acidophilus surface-layer protein in combination with nisin against Staphylococcus aureus publication-title: LWT doi: 10.1016/j.lwt.2020.109208 contributor: fullname: Wang H. – ident: e_1_2_13_26_2 doi: 10.1208/s12249-014-0141-8 – ident: e_1_2_13_28_2 doi: 10.1186/1751-0147-54-69 – volume: 26 year: 2021 ident: e_1_2_13_31_2 article-title: EU-JAMRAI building the European antimicrobial resistance surveillance network in veterinary medicine (EARS-Vet) publication-title: Euro Surveillance contributor: fullname: Mader R. – ident: e_1_2_13_37_2 doi: 10.3390/ijerph192114134 – ident: e_1_2_13_13_2 doi: 10.15376/biores.18.1.1554-1576 – volume: 59 year: 2020 ident: e_1_2_13_19_2 article-title: Comparison of agar dilution to broth microdilution for testing in vitro activity of cefiderocol against gram-negative bacilli publication-title: Journal of Clinical Microbiology doi: 10.1128/JCM.00966-20 contributor: fullname: Albano M. – ident: e_1_2_13_15_2 doi: 10.1371/journal.pone.0007499 – ident: e_1_2_13_61_2 doi: 10.1128/aac.00442-17 – volume: 7 year: 2012 ident: e_1_2_13_58_2 article-title: Glycerol monolaurate antibacterial activity in broth and biofilm cultures publication-title: PLoS One doi: 10.1371/journal.pone.0040350 contributor: fullname: Schlievert P. M. – ident: e_1_2_13_60_2 doi: 10.1186/s40064-016-3182-5 – ident: e_1_2_13_16_2 doi: 10.1128/jcm.01864-19 – ident: e_1_2_13_2_2 doi: 10.1089/mdr.2018.0033 – volume: 1 start-page: 71 year: 2018 ident: e_1_2_13_41_2 article-title: Study of antibiotic resistance pattern in methicillin-resistant Staphylococcus aureus isolated from clinical samples of hospitals in Tabriz–Iran publication-title: International Journal of Biomedicine and Public Health contributor: fullname: Jafari-Sales A. – ident: e_1_2_13_57_2 doi: 10.3390/diseases9040080 – ident: e_1_2_13_55_2 doi: 10.1089/mdr.2020.0001 – ident: e_1_2_13_25_2 doi: 10.1128/aac.47.4.1391-1394.2003 – ident: e_1_2_13_10_2 doi: 10.1038/nrmicro2415 – volume: 11 year: 2020 ident: e_1_2_13_35_2 article-title: Natural anti-biofilm agents: strategies to control biofilm-forming pathogens publication-title: Frontiers in Microbiology doi: 10.3389/fmicb.2020.566325 contributor: fullname: Mishra R. – ident: e_1_2_13_4_2 doi: 10.1016/j.vetmic.2008.09.011 – ident: e_1_2_13_44_2 doi: 10.1186/s40360-017-0141-x – ident: e_1_2_13_8_2 doi: 10.1038/s41522-022-00306-y – ident: e_1_2_13_39_2 doi: 10.5144/0256-4947.2012.513 – ident: e_1_2_13_40_2 doi: 10.22207/jpam.17.1.44 – ident: e_1_2_13_24_2 doi: 10.1186/s12906-021-03293-3 – ident: e_1_2_13_21_2 doi: 10.1186/s13104-018-3820-9 – ident: e_1_2_13_9_2 doi: 10.1038/nrmicro.2016.94 – ident: e_1_2_13_7_2 doi: 10.3390/antibiotics9020059 – ident: e_1_2_13_33_2 doi: 10.1002/jobm.201700071 – volume: 13 year: 2021 ident: e_1_2_13_59_2 article-title: Inhibitory and eradication activities of 1-monolaurin as anti-biofilm on monospecies and polymicrobial of Staphylococcus epidermidis and Candida tropicalis publication-title: International Journal of Pharmaceutical Research contributor: fullname: Mochtar C. F. – ident: e_1_2_13_17_2 doi: 10.1111/j.1469-0691.2011.03570.x – ident: e_1_2_13_12_2 doi: 10.1155/2016/5751785 – ident: e_1_2_13_49_2 doi: 10.1016/j.lwt.2016.03.045 – ident: e_1_2_13_46_2 doi: 10.1007/s13204-014-0301-x – ident: e_1_2_13_20_2 doi: 10.3390/antibiotics11081083 – ident: e_1_2_13_45_2 doi: 10.1007/s43994-022-00018-1 – ident: e_1_2_13_34_2 doi: 10.1128/aac.02008-12 – ident: e_1_2_13_5_2 doi: 10.1385/1-59745-468-0:127 – ident: e_1_2_13_54_2 doi: 10.1038/nrd1008 |
SSID | ssj0068259 |
Score | 2.3429015 |
Snippet | Methicillin-resistant
(MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various antibiotics. This study... Background . Methicillin‐resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life‐threatening infections, showing resistance... Background. Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to... Methicillin-resistant Staphylococcus aureus (MRSA) is one of the major pathogens associated with life-threatening infections, showing resistance to various... |
SourceID | doaj proquest gale crossref pubmed |
SourceType | Open Website Aggregation Database Index Database |
StartPage | 7518368 |
SubjectTerms | Amides Antibiotics Antimicrobial agents Bacteria Biofilms Catheters Cell culture Dilution Drug resistance Drug resistance in microorganisms Electron microscopy Gene expression Glycerol Gram-positive bacteria Health aspects Imipenem Impact resistance Infection Medical instruments Methicillin Microorganisms Polymerase chain reaction Reverse transcription Scanning electron microscopy Staphylococcus aureus Staphylococcus aureus infections Staphylococcus infections Synergistic effect Tetracycline Tetracyclines Tissue culture Wound infection β-Lactam antibiotics |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiDeBglwJxClqEtuxc1yqVm2lckBU9Gb5NWgP9Vbd7IFfwN9mJs6uWjhw4ZQocRTbM-P5xpl8w9gH2cZkMNypJXrPWuJqULuUfK099Kk3RP9C-x0XX_rTS3l-pa7ulPqinLBCD1wm7tDLXrg-hcaZKIOKTkZ0ql2jfDApQGEvbYZtMFXW4B7jnmGb5q4URfjykD4wCKJUveOAJp7-v1fjPzDm5GtOnrDHM0jki9K5p-xBys_Yw1I28udz9muRx-X1cqJQwmYuR05X_JLKb1_zRSgVIfgKOJosxq60o87dD7dELMgvEqW40zZLrr-mNeHHPHIEnTjh6NlWIWzWHB9JeDhDzUQwGjn9hcK_Uwkmfjanb-X1C3Z5cvzt6LSeCyrUQWg91i3o2LkOpG_biNBDx9DHKIIS0UHrdZcAZONVBDwfADoH0unUdU4Hp9tWvGR7eZXTa8ZRlgLf5jVAkk7CAFG4AMEbqnc1yIp93M6yvSm8GXaKN5SyJA07S6Nin0kEuzbEdj1dQB2wsw7Yf-lAxT6RAC3Z5Hjrgpt_LcCuEruVXRhi0cG4e6jY_r2WaEvh_u2tCtjZltdWEHWqMoPBQR3sbtOTlJ-W02oztaHPTMI0FXtVVGc3JDEgpkJU9uZ_DPUte0TTVzaB9tneeLtJ7xAWjf79ZAG_AeKUDsM priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k2gICOBOEVdx3bsnNCCqFqkckBU7M3ys9pDnbLJHvgF_G1mEu9CQeKUKHaeM2N_M558Q8hrwULU4O7UAmbPWsBoUNsYXa1camOrkf4F4x1nn9uTc_FpJVcl4DaUtMrdmDgN1KH3GCM_4khgKXWnxbur7zVWjcLV1VJC4ya5xRpQXtBntdo7XC14Pwh_WQuG1DG92iW-S4k-vzjCJQeOJKt_TEkTc_-_4_NfqHOafY7vkbsFNtLlLOf75EbMD8jtuZDkj4fk5zKP68v1RKoE3WwOFI-4NRbkvqRLP9eIoH2iYMTgzWKMndoLuwZ0SM8iJr1j4CXXX-KAiDKPFGAoiADmut777UDhlAibU9BVgKeB4n8p9BsWZaKnJaErD4_I-fHHrx9O6lJiofZcqbFmSYXGNkk4xgKAERV8GwL3kgebmFNNTEksnAwJ9ruUGpuEVbFprPJWMcYfk4Pc5_iUUJAuh7s5lVIUVqQuBW598k5jBaxOVOTN7iubq5lJw0weiJQGpWGKNCryHkWw74P819OBfnNhijkZJ1pu2-gXVgfhZbAiANRqFtJ5HX2SFXmLAjRopePGelt-NoBHRb4rs9TIqwOeeFeRw2s9wbr89eadCphi3YP5rYsVebVvxjMxYy3Hfjv1wYUnrhcVeTKrzv6VeAcoC3Das_9f_Dm5gx9mDvgckoNxs40vAAKN7uWk578AzrgHJg priority: 102 providerName: ProQuest |
Title | Antimicrobial and Antibiofilm Activity of Monolaurin against Methicillin-Resistant Staphylococcus aureus Isolated from Wound Infections |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39129910 https://www.proquest.com/docview/3091358984 https://www.proquest.com/docview/3092009380 https://doaj.org/article/b463a6ec0a8d4c5da4d639205bc8ecf5 |
Volume | 2024 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELb2ISQuiPcWlspIIE6BOrZj54BQF-3SRdoVqqjILfJzVYlNoE0l9hfwt5nJo1IXDlySKLHV2jMTfzOefEPIK8F80ODuJAJWz0TA2yAxIdhE2ZiFTCP9C8Y7Li6z2UJ8LmSxR4Zqo_0Erv_p2mE9qcXq-9tfP28-gMG_bw1eSvTfxTvcPuCZ3ieHKVJyYRKf2O4nZOAHIRBmGZhUznQxpMDf6r2zOLUc_n-_qW_hz3YdOrtP7vUAkk47iT8ge6F6SO50JSVvHpHf06pZXi9beiVoZipP8Y5dYmnuazp1XbUIWkcK5gyDx2g7NVdmCTiRXgRMf8cQTJXMwxqxZdVQAKQgDFj1auc2awpdApzOQWsBqHqKX6jQb1ieiZ73qV3V-jFZnJ1-_ThL-mILieNKNQmLyqcmjcIy5gGWKO8y77mT3JvIrEpDjGJipY9wnceYmiiMCmlqlDOKMf6EHFR1FY4IBTlz-DWrYgzCiJhHz42LzmqshZWLEXk9zHL5o-PUKFtfRMoSpVH20hiRExTBtg0yYbc36tVV2RtWaUXGTRbcxGgvnPRGeABd6URap4OLckTeoABL1KBmZZzpPzuAv4rMV-VUI8MO-OT5iBzvtAQ7c7uPBxUoBzUtOdKqSp1rGNTL7WPsiblrVag3bRvcguJ6MiJPO9XZDonngLcAsT37j97PyV2cnS7-c0wOmtUmvABE1Ngx2VeFGpPDk9PLL_NxG1eA46eCjVszgON8VvwB3-gQYw |
link.rule.ids | 315,783,787,866,867,2109,4033,12070,21402,24332,27937,27938,27939,31733,31734,33758,33759,43324,43819,74081,74638 |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMEF8SwpBYwE4hR1E9uxc0ILotqFbg-oFXuz_Kz20KRssgd-Qf82M4l3oSBxShQ7z5mxvxlPviHkLS98UODu5Bxmz5zDaJCbEGwubaxCpZD-BeMdi9Nqds6_LMUyBdy6lFa5HROHgdq3DmPkRwwJLIWqFf9w9SPHqlG4uppKaNwmd5CHC7nz5XLncFXg_SD8LSowpLpQy23iuxDo8_MjXHJgSLL6x5Q0MPf_Oz7_hTqH2ef4IXmQYCOdjnJ-RG6F5jG5OxaS_PmEXE-bfnW5GkiVoJtpPMUjdoUFuS_p1I01ImgbKRgxeLMYY6fmwqwAHdJFwKR3DLw0-bfQIaJsegowFEQAc13r3KajcEqAzRx0FeCpp_hfCv2ORZnoPCV0Nd1Tcn78-ezTLE8lFnLHpOzzIkpfmjJyWxQewIj0rvKeOcG8iYWVZYiRT6zwEfbrGEsTuZGhLI10RhYFe0b2mrYJzwkF6TK4m5UxBm54rKNnxkVnFVbAqnlG3m2_sr4amTT04IEIoVEaOkkjIx9RBLs-yH89HGjXFzqZk7a8YqYKbmKU5054wz1ArXIirFPBRZGR9yhAjVbar40z6WcDeFTku9JThbw64InXGTm80ROsy91s3qqATtbd6d-6mJE3u2Y8EzPWmtBuhj648MTUJCP7o-rsXonVgLIApx38_-Kvyb3Z2eJEn8xPv74g9_EjjcGfQ7LXrzfhJcCh3r4adP4XWKMKFg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwELZgEYgL4rlkWcBIIE5Rm9iOnRMqj2oL7AohVvRm-bnqYZPdJj3wC_jbzCRuYUHi1Cp2mjQz4_lmPPmGkJe88EFBuJNz8J45h9UgNyHYXNpYhUoh_QvmO45PqqNT_nEplqn-qUtllds1cViofeswRz5hSGApVK34JKayiC_v528uLnPsIIU7ramdxnVyQ3JwdKDbcrkLviqIhBAKFxUYVV2o5bYIXgiM__kEtx8YEq7-4Z4GFv9_1-q_EOjgieZ3yZ0EIelslPk9ci0098nNsankjwfk56zpV-ergWAJppnGUzxiV9ic-5zO3NgvgraRgkFDZIv5dmrOzAqQIj0OWACPSZgm_xo6RJdNTwGSgjjA77XObToKpwT4WIDeAlT1FN9Rod-xQRNdpOKupntITucfvr07ylO7hdwxKfu8iNKXpozcFoUHYCK9q7xnTjBvYmFlGWLkUyt8hO91jKWJ3MhQlkY6I4uCPSJ7TduEx4SCpBlczcoYAzc81tEz46KzCrth1Twjr7ZPWV-MrBp6iEaE0CgNnaSRkbcogt0c5MIeDrTrM51MS1teMVMFNzXKcye84R5gVzkV1qngosjIaxSgRovt18aZ9OIB3CpyX-mZQo4diMrrjBxemQmW5q4Ob1VAJ0vv9G-9zMiL3TCeidVrTWg3wxzchGJqmpH9UXV2f4nVgLgAsx38_8efk1ug7vrz4uTTE3Ibn9GYBzoke_16E54CMurts0HlfwG-4g5L |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antimicrobial+and+Antibiofilm+Activity+of+Monolaurin+against+Methicillin-Resistant+Staphylococcus+aureus+Isolated+from+Wound+Infections&rft.jtitle=International+journal+of+microbiology&rft.au=Hassan+Abd+El-Ghany%2C+Shimaa+Salah&rft.au=Azmy%2C+Ahmed+Farag&rft.au=Osama+El-Gendy%2C+Ahmed&rft.au=Abd+El-Baky%2C+Rehab+Mahmoud&rft.date=2024&rft.issn=1687-918X&rft.volume=2024&rft.spage=7518368&rft_id=info:doi/10.1155%2F2024%2F7518368&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1687-918X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1687-918X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1687-918X&client=summon |